Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine

Acta Psychiatrica Scandinavica

Volumn 106, Issue 4, 2002, Pages 314-319

  Kampman, M ^a,b   Keijsers, G P J ^a   Hoogduin, C A L ^a   Verbraak, M J P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGz Nijmegen   (Netherlands)

Author keywords

Cognitive behaviour therapy; Fluoxetine; Obsessive compulsive disorder

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMPULSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROSIS; OBSESSION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FLUOXETINE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036789108     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2002.01261.x     Document Type: Article

References (17)

1. American Psychiatric Association (ed.) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th edn. Washington DC: American Psychiatric Association, 1994.
2. MARCH JS, FRANCES A, CARPENTER D, KAHN DA. Treatment of obsessive-compulsive disorder. J Clin Psychiat 1997;58(Suppl. 4):1-73.
3. ZOHAR J, WESTENBERG HGM. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 2000;101(Suppl. 403):39-49.
4. ABRAMOWITZ JS. Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder: a meta-analysis. Behav Ther 1996;27:583-600.
5. BALLENGER JC. Current treatment of the anxiety disorders in adults. Biol Psychiat 1999;46:1579-1594.
6. SIMPSON HB, GORFINKLE KS, LIEBOWITZ MR. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. J Clin Psychiat 1999;60:584-590.
7. BOUMAN TK, DE RUITER C, HOOGDUIN CAL. Nederlandse vertaling en bewerking van het Anxiety Disorders Interview Schedule for DSM-IV. ADIS-IV-NL [Dutch version of the Anxiety Disorders Intervies for DSM-IV, ADIS-IV-NL], 1997.
8. DINARDO PA, BROWN TA. BARLOW DH. Anxiety Disorders Interview Schedule for DSM-IV. Life Time Version. Albany, NY: Graywind Publications Inc., 1994.
9. PIGOTT AT, SEAY S. Pharmacotherapy of obsessive-compulsive disorder: Overview and treatment-refractory strategies. In: GOODMAN WK et al., ed. Obsessive-Compulsive Disorder; Contemporary Issues in Treatment. Mahwah, NJ: Lawrence Erlbaum Associates, Publishers, 2000: 277-302.
10. GOODMAN WK, PRICE LH, RASMUSSEN SA et al. The Yale-Brown Obsessive-Compulsive Scale; development, use and reliability. Arch General Psychiatry 1989;46:1006-1011.
11. VERBRAAK MJPM, HOOGDUIN CAL, METHORST GJ, ARTS WJJM, HANSEN AMD, KEIJSERS GPJ. Protocollaire behandeling van patiënten met een obsessief-compulsieve stoornis: Exposure, responspreventie en cognitieve therapie [Manualised treatment for patients with an obsessive-compulsive disorder: Exposure, response prevention and cognitive therapy]. In: KEIJSERS GPJ et al., ed. Protocollaire Behandelingen in de Ambulante Geestelijke Gezondheidszorg. Houten/Diegem: Bohn Stafleu Van Loghum. 1997: 158-182.
12. BECH P, KASTRUP M, RAFAELASEN OJ. Minicompendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 1986;73(Suppl. 326):1-37.
13. HOFFART A, DUE-MADSEN J, LANDE B, GUDE T, BILLE H, TORGERSEN S. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy. J Clin Psychiat 1993;54:481-487.
14. KAMPMAN M, KEIJSERS GPJ, HOOGDUIN CAL, HENDRIKS GJ. A randomised, double-blind, placebo-controlled study into the effects of additional paroxetine in panic disorder patients, unsuccessfully treated with cognitive behaviour therapy. J Clin Psychiat (in press).
15. OTTO MW, POLLACK MH, PENEVA SJ, ZUCKER BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther 1999;37:763-770.
16. POLLACK MH, OTTO MW, KASPI SP, HAMMERNESS PG, ROSENBAUM JF. Cognitive-behavior therapy for treatment refractory panic disorder. J Clin Psychiat 1994;55:200-205.
17. DE HAAN E, VAN OPPEN P, VAN BALKOM AJLM SPINHOVEN P, HOOGDUIN KAL, VAN DYCK R. Prediction of outcome and early vs. late improvement in OCD patients treated with cognitive behaviour therapy and pharmacotherapy. Acta Psychiatr Scand 1997;96:354-361.